Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2) Peptide
IGF2BP2
Reactivity: Human
Host: Synthetic
BP, BI
-
- Target See all IGF2BP2 products
- IGF2BP2 (Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- IGF2BP2 peptide corresponds to 15 amino acids of IGF2BP2.
-
Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2) peptide
IGF2BP2 Reactivity: Human, Dog, Mouse Host: Synthetic BP, Imm
-
- Application Notes
- IGF2BP2 Peptide is used for blocking the activity of IGF2BP2 antibody . The IGF2BP2 antibody ships at 0.5 mg/mL and the IGF2BP2 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- IGF2BP2 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Target
- IGF2BP2 (Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2))
- Synonyms
- IMP-2 Peptide, IMP2 Peptide, VICKZ2 Peptide, p62 Peptide, C330012H03Rik Peptide, Imp2 Peptide, Neilsen Peptide, RGD1305614 Peptide, insulin like growth factor 2 mRNA binding protein 2 Peptide, insulin-like growth factor 2 mRNA binding protein 2 Peptide, IGF2BP2 Peptide, Igf2bp2 Peptide
- Gene ID
- 10644
- NCBI Accession
- NP_006539, NP_001007226
- OMIM
- 64085377
- UniProt
- Q9Y6M1
-
You are here:
